Compass Therapeutics (CMPX) Tax Provisions (2019 - 2021)

Compass Therapeutics (CMPX) has 3 years of Tax Provisions data on file, last reported at -$13000.0 in Q4 2021.

• For the quarter ending Q4 2021, Tax Provisions changed N/A year-over-year to -$13000.0; the trailing twelve-month figure through Sep 2022 stood at -$13000.0 (down 120.31% YoY), and the FY2020 full-year result was $32000.0, down 64.84% from the prior year.
• Tax Provisions retreated to -$13000.0 in Q4 2021, from $32000.0 in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $81000.0 in Q3 2019 to a low of -$13000.0 in Q4 2021.
• A 3-year average of $33833.3 and a median of $32000.0 in 2020 frame the typical range for Tax Provisions.
• Peak annual rise in Tax Provisions reached 41.82% in 2020, while the deepest fall reached 60.49% in 2020.
• Tracing CMPX's Tax Provisions over 3 years: stood at $81000.0 in 2019, then sank by 60.49% to $32000.0 in 2020, then plunged by 140.62% to -$13000.0 in 2021.
• Business Quant data shows CMPX's Tax Provisions at -$13000.0 in Q4 2021, $32000.0 in Q3 2020, and $32000.0 in Q2 2020.